| Stage | CON | % of rev | ACHC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $606M | 100.00% | $866M | 100.00% | ACHC ×1.43 |
| Gross profit | $192M | 31.70% | $392M | 45.24% | ACHC +13.5pp |
| Operating income | $115M | 18.99% | $60M | 6.95% | CON +12.0pp |
| Pre-tax income | $89M | 14.74% | $22M | 2.54% | CON +12.2pp |
| Net income | $67M | 11.10% | $12M | 1.42% | CON +9.7pp |
| Stage | CON | ACHC | Gap · A − B |
|---|---|---|---|
| Revenue | $606M100.00% | $866M100.00% | ACHC ×1.43 |
| Gross profit | 31.70%$192M | 45.24%$392M | ACHC +13.5pp |
| Operating income | 18.99%$115M | 6.95%$60M | CON +12.0pp |
| Pre-tax income | 14.74%$89M | 2.54%$22M | CON +12.2pp |
| Net income |
| 11.10%$67M |
| 1.42%$12M |
| CON +9.7pp |
No shared counterparties.